Glow-in-the-dark dye helps surgeons spot hidden cancer in children
NCT ID NCT07399821
First seen Apr 04, 2026 · Last updated Apr 28, 2026 · Updated 3 times
Summary
This study tests a special fluorescent dye (anti-GD2-800CW) that makes neuroblastoma tumors glow during surgery. About 22 children aged 1 to 18 will receive the dye before their standard tumor removal surgery. The goal is to find a safe and effective dose so surgeons can better see and remove all cancer tissue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Prinses Maxima Centrum
RECRUITINGUtrecht, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.